Cargando…

CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance

CITED2 (Cbp/p300‐interacting transactivator, with Glu/Asp‐rich carboxy‐terminal domain, 2) is a member of the CITED family and is involved in various cellular functions during development and differentiation. Mounting evidence suggests the importance of CITED in the progression of human malignancies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minemura, Hiroyuki, Takagi, Kiyoshi, Sato, Ai, Takahashi, Hikaru, Miki, Yasuhiro, Shibahara, Yukiko, Watanabe, Mika, Ishida, Takanori, Sasano, Hironobu, Suzuki, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198946/ https://www.ncbi.nlm.nih.gov/pubmed/27627783 http://dx.doi.org/10.1111/cas.13081

Ejemplares similares

Abnormal expression of miR‐1 in breast carcinoma as a potent prognostic factor
por: Minemura, Hiroyuki, et al.
Publicado: (2015)

TACC2 (transforming acidic coiled‐coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation
por: Onodera, Yoshiaki, et al.
Publicado: (2016)

ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens
por: Takagi, Kiyoshi, et al.
Publicado: (2018)

Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis
por: Chishiki, Mayuko, et al.
Publicado: (2017)

GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor
por: Takagi, Kiyoshi, et al.
Publicado: (2014)

OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor‐positive breast carcinoma
por: Mayama, Akifumi, et al.
Publicado: (2018)

ODP548 Fatty acid metabolism-related factors in breast and endometrial cancers
por: Miki, Yasuhiro, et al.
Publicado: (2022)

Forkhead Box I1 in Breast Carcinoma as a Potent Prognostic Factor
por: Onodera, Yoshiaki, et al.
Publicado: (2021)

Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment
por: Sakurai, Minako, et al.
Publicado: (2017)

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway
por: Iwabuchi, Erina, et al.
Publicado: (2021)

Immunolocalization of Corticotropin-Releasing Hormone (CRH) and Its Receptors (CRHR1 and CRHR2) in Human Endometrial Carcinoma: CRHR1 as a Potent Prognostic Factor
por: Sato, Naoko, et al.
Publicado: (2014)

Aromatase in human liver and its diseases
por: Hata, Shuko, et al.
Publicado: (2013)

Microtubule-Associated Protein 2 as a DHEA Binding Protein in Endometrial Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2021)

p62/sequestosome 1 in human colorectal carcinoma as a potent prognostic predictor associated with cell proliferation
por: Nakayama, Shun, et al.
Publicado: (2017)

ODP562 ZnT5 Involvement in EMT in Breast Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2022)

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway in Breast Cancer
por: Iwabuchi, Erina, et al.
Publicado: (2021)

Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor
por: Ebata, Akiko, et al.
Publicado: (2023)

ODP543 Chemotherapy-induced extracellular HSP70 enhances pro-tumorigenic effects of macrophages in breast cancers.
por: Yamaguchi, Mio, et al.
Publicado: (2022)

Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells
por: Yamaguchi, Mio, et al.
Publicado: (2021)

An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma
por: Masuda, Mariko, et al.
Publicado: (2012)

Exploring Protein–Protein Interaction in the Study of Hormone-Dependent Cancers
por: Miki, Yasuhiro, et al.
Publicado: (2018)

Roles of Aryl Hydrocarbon Receptor in Aromatase-Dependent Cell Proliferation in Human Osteoblasts
por: Miki, Yasuhiro, et al.
Publicado: (2017)

L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism
por: Sato, Miku, et al.
Publicado: (2021)

The Visualization of Protein-Protein Interactions in Breast Cancer: Deployment Study in Pathological Examination
por: Iwabuchi, Erina, et al.
Publicado: (2021)

Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor
por: Verma, Mohit K, et al.
Publicado: (2013)

Quantitative diagnosis of HER2 protein expressing breast cancer by single‐particle quantum dot imaging
por: Miyashita, Minoru, et al.
Publicado: (2016)

Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast
por: Yoda, Tomomi, et al.
Publicado: (2014)

ODP559 The prognostic role of IL-17A-neutrophils crosstalk in triple-negative breast cancer
por: Khalid, Freeha, et al.
Publicado: (2022)

Diverse role of androgen action in human breast cancer
por: Takagi, Kiyoshi, et al.
Publicado: (2022)

Immunolocalization of CD80 and CD86 in Non-Small Cell Lung Carcinoma: CD80 as a Potent Prognostic Factor
por: Sato, Takashi, et al.
Publicado: (2022)

Visualization of the protein–protein interactions of hormone receptors in hormone-dependent cancer research
por: Iwabuchi, Erina, et al.
Publicado: (2022)

Phase Two Steroid Metabolism and Its Roles in Breast and Prostate Cancer Patients
por: McNamara, Keely M., et al.
Publicado: (2013)

An inhibition of p62/SQSTM1 caused autophagic cell death of several human carcinoma cells
por: Nihira, Kaito, et al.
Publicado: (2014)

In Situ Evaluation of Estrogen Receptor Dimers in Breast Carcinoma Cells: Visualization of Protein-Protein Interactions
por: Iwabuchi, Erina, et al.
Publicado: (2017)

OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy
por: Shibahara, Ichiyo, et al.
Publicado: (2015)

The Pro-Tumorigenic Role of Chemotherapy-Induced Extracellular HSP70 from Breast Cancer Cells via Intratumoral Macrophages
por: Yamaguchi-Tanaka, Mio, et al.
Publicado: (2023)

PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells
por: Inoue, Chihiro, et al.
Publicado: (2019)

The Significance of MMP-1 in EGFR-TKI–Resistant Lung Adenocarcinoma: Potential for Therapeutic Targeting
por: Saito, Ryoko, et al.
Publicado: (2018)

EphB4 as a Novel Target for the EGFR-Independent Suppressive Effects of Osimertinib on Cell Cycle Progression in Non-Small Cell Lung Cancer
por: Nanamiya, Ren, et al.
Publicado: (2021)

The correlation of p22(phox) and chemosensitivity in EGFR-TKI resistant lung adenocarcinoma
por: Kobayashi, Masayuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r06v0r3blj410ph20rf4d25kts